New 52 Week High Today

Harrow Health Inc HROW:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 02/03/23 EST
17.50UNCH (UNCH)
Volume
41,282
Close
17.50quote price arrow up+1.34 (+8.29%)
Volume
491,468
52 week range
5.40 - 17.84
Loading...
  • Open15.99
  • Day High17.84
  • Day Low15.99
  • Prev Close16.16
  • 52 Week High17.84
  • 52 Week High Date02/03/23
  • 52 Week Low5.40
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap515.388M
  • Shares Out29.45M
  • 10 Day Average Volume0.19M
  • Dividend-
  • Dividend Yield-
  • Beta0.20
  • YTD % Change18.56

KEY STATS

  • Open15.99
  • Day High17.84
  • Day Low15.99
  • Prev Close16.16
  • 52 Week High17.84
  • 52 Week High Date02/03/23
  • 52 Week Low5.40
  • 52 Week Low Date05/12/22
  • Market Cap515.388M
  • Shares Out29.45M
  • 10 Day Average Volume0.19M
  • Dividend-
  • Dividend Yield-
  • Beta0.20
  • YTD % Change18.56

RATIOS/PROFITABILITY

  • EPS (TTM)-0.83
  • P/E (TTM)-21.15
  • Fwd P/E (NTM)113.64
  • EBITDA (TTM)4.962M
  • ROE (TTM)-253.39%
  • Revenue (TTM)88.454M
  • Gross Margin (TTM)72.53%
  • Net Margin (TTM)-25.50%
  • Debt To Equity (MRQ)5,935.83%

EVENTS

  • Earnings Date03/08/2023(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Harrow Health Inc

 

Profile

MORE
Harrow Health, Inc. is an eyecare pharmaceutical company. The Company serves ophthalmologists and optometrists by providing branded ophthalmic pharmaceuticals and compounded prescription medicines. The Company's business specializes in the development, production and sale of medications that serve unmet needs in the marketplace through its subsidiaries and deconsolidated companies. Its five branded ophthalmic products include ILEVRO, NEVANAC, VIGAMOX, MAXIDEX, and TRIESENCE....
Mark Baum J.D.
Chairman of the Board, Chief Executive Officer
Andrew Boll
Chief Financial Officer, Corporate Secretary
Address
102 WOODMONT BLVD, SUITE 610
Nashville, TN
37215
United States

Top Peers

SYMBOLLASTCHG%CHG
ESPR
Esperion Therapeutics Inc
5.90-0.02-0.34%
OCUL
Ocular Therapeutix Inc
4.32+0.08+1.89%
OMER
Omeros Corp
3.09-0.06-1.90%
OPTN
OptiNose Inc
1.75-0.07-3.85%
AVDL
Avadel Pharmaceuticals PLC
7.69+0.03+0.39%